EXTRACTION & EVALUATION OF SOYABEAN MILK PEPTIDE FOR THE TREATMENT OF CANCER & Diabetes IN TRASGENIC NUDE MICE & KK-Ay mice EXPERIMENTAL model.

Soy milk, also known as soya milk, is a plant-based beverage made from soybeans. It's produced by soaking and grinding soybeans, boiling the mixture, and then filtering out the remaining solids. This results in a stable emulsion of oil, water, and protein. Soy milk is a popular alternative to dairy milk, particularly for those with lactose intolerance. 

Extract peptide from soyabean milk .

Nude mice, characterized by a genetic mutation leading to a deficient immune system, are widely used in cancer research as a model for studying tumor growth and testing potential treatments. The mutation, primarily affecting the FOXN1 gene, results in a lack of functional T cells, preventing the rejection of transplanted tumors (xenografts). This allows researchers to transplant human cancer cells into nude mice and observe tumor development, metastasis, and response to therapies.

Peptides are increasingly used in cancer treatment, both as direct therapies and as components of drug delivery systems. They offer a promising approach due to their ability to target specific cancer cells, modulate the immune system, and potentially overcome limitations of traditional treatments. 

Types of Peptides Used in Cancer Treatment:

Anticancer Peptides (ACPs):
These are small, cationic peptides with intrinsic anticancer activity, often exhibiting antimicrobial properties as well. They can disrupt cell membranes, induce apoptosis (programmed cell death), or interfere with cell signaling pathways. Examples include LL-37, Indolicidin, and Tritrpticin. 

Tumor-Homing Peptides (THPs):
These peptides are designed to selectively target and bind to cancer cells or the tumor microenvironment. They are used to deliver therapeutic agents directly to the tumor site, potentially reducing off-target effects and improving efficacy. 

Cell-Penetrating Peptides (CPPs):
CPPs are short peptides that can penetrate cell membranes, making them useful for delivering therapeutic molecules, such as nucleic acids or drugs, into cells. 

Peptide-Based Vaccines:
Peptides can be used to stimulate the immune system to recognize and attack cancer cells. These vaccines often consist of short peptide sequences that mimic portions of tumor-associated antigens. 

Peptide Hormones:
Certain peptide hormones, like LHRH agonists and antagonists, are used in hormone-sensitive cancers like prostate cancer to reduce hormone levels and slow tumor growth. 

Mechanisms of Action:

Direct Cytotoxicity:
Some peptides directly kill cancer cells by disrupting cell membranes, inducing apoptosis, or interfering with essential cellular processes. 

Immune Stimulation:
Peptides can be used to activate or modulate immune cells, such as T cells and natural killer cells, to target and destroy cancer cells. 

Targeted Delivery:
Peptides can be conjugated to drugs or other therapeutic agents to deliver them specifically to cancer cells, improving their effectiveness and reducing toxicity to healthy tissues. 

Gene Therapy:
Peptides can be used to deliver nucleic acids, such as siRNA or mRNA, into cancer cells to silence genes involved in tumor growth or drug resistance. 

Methods for Peptide Extraction:

1. Enzymatic Hydrolysis:

Milk proteins are treated with specific enzymes (e.g., pepsin, trypsin, chymotrypsin) to cleave peptide bonds. 

The choice of enzyme and reaction conditions (pH, temperature, substrate ratio) influences the peptide profile. 

Enzymes like trypsin and chymotrypsin are specific for certain amino acids, allowing for targeted peptide production. 

Pepsin is used for acidic hydrolysis, cleaving peptide bonds at the carboxyl side of aromatic amino acids. 

2. Microbial Fermentation:

Milk is fermented using proteolytic starter cultures (bacteria) that produce enzymes to break down proteins. 

This process can release bioactive peptides with various functionalities. 

3. Novel Technologies:

Ultrasound: Cavitation and shear forces disrupt protein structure, enhancing enzymatic hydrolysis. 

Microwave: Offers rapid heating, easy operation, and energy efficiency. 

High-Pressure Processing: Alters protein conformation, making them more susceptible to enzymatic action. 

4. Chemical Synthesis:
While less common for large-scale production, chemical synthesis can be used to produce specific peptides. 

5. Purification and Characterization:

After hydrolysis or fermentation, peptides can be purified using techniques like ultrafiltration, chromatography (e.g., RP-HPLC), and mass spectrometry. 

Purified peptides can then be characterized to identify their sequences and biological activities. 

The KK-Ay mouse is a widely used experimental model for type 2 diabetes mellitus. It's characterized by obesity, hyperglycemia, and the development of diabetic nephropathy, making it a suitable model for studying the early stages of this disease in humans.

Here's a more detailed explanation:

Key Characteristics of the KK-Ay Mouse Model:

• Origin:The KK-Ay mouse was developed by introducing the yellow obese gene (Ay allele) into the KK/Ta mouse strain.
• Obesity and Hyperglycemia:These mice exhibit obesity and hyperglycemia, including elevated levels of HbA1c and albuminuria.
• Diabetic Nephropathy:The KK-Ay mouse develops renal lesions that closely resemble those seen in human diabetic nephropathy, particularly in the early stages.
• Pathological Changes in Kidneys:These include diffuse mesangial expansion, mesangial cell proliferation, and segmental sclerosis, which are more severe than those observed in KK/Ta mice.
• Suitable for Early Stages:The KK-Ay mouse is considered a suitable model for studying the early stages of type 2 diabetic nephropathy, due to the similarity of the renal lesions.

Why KK-Ay Mice are Used as a Model:

• Relevance to Human Type 2 Diabetes:The KK-Ay mouse model shares many characteristics with human type 2 diabetes, including obesity, hyperglycemia, and kidney complications.
• Early Onset:This model develops diabetic symptoms relatively early, allowing for the study of the disease's progression over time.
• Research Applications:KK-Ay mice are used in research to:Study the pathogenesis of type 2 diabetes.Evaluate the effectiveness of new anti-diabetic drugs.Investigate the development and progression of diabetic complications, particularly nephropathy.

MARS- MAHATMA RAKESH SINGH